# A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure

> **NCT00537043** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** SK&F-105517 (COREG CR FDC)

## Key facts

- **NCT ID:** NCT00537043
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537043, "A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00537043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*